The risks of pulmonary embolism and upper gastrointestinal bleeding beyond 35 days after total hip replacement for coxarthrosis among middle-aged patients: A cross-over cohort
详细信息 查看全文
- 作者：Gré ; goire Ficheur ; MD ; PhDa ; gregoire.ficheur@univ-lille2.fr" class="auth_mail" title="E-mail the corresponding author ; Alexandre Caron ; MDa ; Jean-Baptiste Beuscart ; MD ; PhDb ; Laurie Ferret ; PharmD ; PhDc ; Sophie Putman ; MDd ; Ré ; gis Beuscart ; MD ; PhDa ; Emmanuel Chazard ; MD ; PhDa
- 关键词：Patient safety ; Venous thromboembolic event ; Bleeding event ; Total hip arthroplasty ; Total hip replacement
- 刊名：Preventive Medicine
- 出版年：2016
- 出版时间：December 2016
- 年：2016
- 卷：93
- 期：Complete
- 页码：121-127
- 全文大小：555 K
文摘
- •
After total hip replacement (THR), anticoagulation is recommended up to 35 days.
- •
Both risks of thrombotic and bleeding events have not been assessed at the same time in population-based studies.
- •
We conducted a cross-over cohort from 2007 to 2013 in France, among middle-aged patients.
- •
The risk of pulmonary embolism remains elevated beyond 35 days after THR.
- •
The risk of upper gastrointestinal bleeding is no more elevated beyond 35 days.